Heterogenous high-level HER-2 amplification in a small subset of colorectal cancers-Reference-Cited by-同舟云学术

Heterogenous high-level HER-2 amplification in a small subset of colorectal cancers

Published:2010-11 Issue:11 Volume:41 Page:1577-1585
ISSN:0046-8177
Container-title:Human Pathology
language:en
Short-container-title:Human Pathology

Author:

Marx Andreas H.,Burandt Eike C.,Choschzick Matthias,Simon Ronald,Yekebas Emre,Kaifi Jussuf T.,Mirlacher Martina,Atanackovic Djordje,Bokemeyer Carsten,Fiedler Walter,Terracciano Luigi,Sauter Guido,Izbicki Jakob R.

Publisher

Elsevier BV

Subject

Pathology and Forensic Medicine

Reference40 articles.

1. The product of the human c-erbB-2 gene: a 185-kilodalton glycoprotein with tyrosine kinase activity;Akiyama;Science,1986

2. Tyrosine kinase receptor with extensive homology to EGF receptor shares chromosomal location with neu oncogene;Coussens;Science,1985

3. Trastuzumab, a recombinant DNA-derived humanized monoclonal antibody, a novel agent for the treatment of metastatic breast cancer;Goldenberg;Clin Ther,1999

4. Human breast cancer: correlation of relapse and survival with amplification of the HER-2/neu oncogene;Slamon;Science,1987

5. HER-2/neu gene amplification characterized by fluorescence in situ hybridization: poor prognosis in node-negative breast carcinomas;Press;J Clin Oncol,1997

Cited by 78 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. RAS/RAF mutations and microsatellite instability status in primary colorectal cancers according to HER2 amplification;Scientific Reports;2024-05-19

2. Colorectal Cancer and Role of Biomarkers in Diagnosis, Prognostification and Personalized Treatment;Molecular Biomarkers for Cancer Diagnosis and Therapy;2024

3. Targeting HER2 heterogeneity in breast and gastrointestinal cancers;Trends in Cancer;2023-11

4. Effect of human epidermal growth factor receptor 2 overexpression in metastatic colorectal cancer on standard chemotherapy outcomes;Journal of Gastrointestinal Oncology;2023-10

5. The management of oligometastatic disease in colorectal cancer: Present strategies and future perspectives;Critical Reviews in Oncology/Hematology;2023-06